Krismeikesari Krismeikesari. Comparative Efficacy and Safety of Individual SGLT2 Inhibitors (Dapagliflozin, Empagliflozin, and Canagliflozin) on Kidney Function Decline in CKD: A Systematic Review and Network Meta-Analysis. OAIJMR [Internet]. 2025Nov.12 [cited 2026Feb.4];5(6):1772-89. Available from: https://www.hmpublisher.com/index.php/OAIJMR/article/view/818